Related Articles
Phosphorylation of glycogen synthase kinase-3 β at serine 9 confers cisplatin resistance in ovarian cancer cells
microRNA‑199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin
Twist2 promotes ovarian cancer cell survival through activation of Akt
Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma
Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer